Penn Medicine University City — Philadelphia, Pennsylvania

Penn Medicine University City is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Penn Medicine University City has participated in 10 clinical trials with 5 currently active.

Therapeutic areas: Post Bariatric Hypoglycemia, Pulmonary Arterial Hypertension, Sickle Cell Disease.

Sponsors: Amylyx Pharmaceuticals Inc., United Therapeutics, University of Pennsylvania.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Penn Medicine University City?

Penn Medicine University City has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Penn Medicine University City conducted?

Penn Medicine University City has 10 clinical trials on record, with 5 currently active. Their work covers Post Bariatric Hypoglycemia, Pulmonary Arterial Hypertension, Sickle Cell Disease.

Is Penn Medicine University City accredited by Crixeo Health?

Yes — Penn Medicine University City holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Penn Medicine University City?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.